290 related articles for article (PubMed ID: 32568636)
1. Thrombolysis Outcomes in Acute Ischemic Stroke by Fluid-Attenuated Inversion Recovery Hyperintense Arteries.
Zhou Z; Yoshimura S; Delcourt C; Lindley RI; You S; Malavera A; Torii-Yoshimura T; Carcel C; Wang X; Chen X; Parsons MW; Demchuk AM; Wardlaw JM; Mair G; Robinson TG; Chalmers J; Xu J; Anderson CS
Stroke; 2020 Jul; 51(7):2240-2243. PubMed ID: 32568636
[TBL] [Abstract][Full Text] [Related]
2. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
3. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset.
Thomalla G; Simonsen CZ; Boutitie F; Andersen G; Berthezene Y; Cheng B; Cheripelli B; Cho TH; Fazekas F; Fiehler J; Ford I; Galinovic I; Gellissen S; Golsari A; Gregori J; Günther M; Guibernau J; Häusler KG; Hennerici M; Kemmling A; Marstrand J; Modrau B; Neeb L; Perez de la Ossa N; Puig J; Ringleb P; Roy P; Scheel E; Schonewille W; Serena J; Sunaert S; Villringer K; Wouters A; Thijs V; Ebinger M; Endres M; Fiebach JB; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Gerloff C;
N Engl J Med; 2018 Aug; 379(7):611-622. PubMed ID: 29766770
[TBL] [Abstract][Full Text] [Related]
4. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Resonance Imaging-Guided Thrombolysis (0.6 mg/kg) Was Beneficial for Unknown Onset Stroke Above a Certain Core Size: THAWS RCT Substudy.
Toyoda K; Inoue M; Yoshimura S; Yamagami H; Sasaki M; Fukuda-Doi M; Kimura K; Asakura K; Miwa K; Kanzawa T; Ihara M; Kondo R; Shiozawa M; Ohtaki M; Kamiyama K; Itabashi R; Iwama T; Aoki J; Minematsu K; Yamamoto H; Koga M;
Stroke; 2021 Jan; 52(1):12-19. PubMed ID: 33297866
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP Trial.
Cheng B; Boutitie F; Nickel A; Wouters A; Cho TH; Ebinger M; Endres M; Fiebach JB; Fiehler J; Galinovic I; Puig J; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Gerloff C; Thomalla G;
Stroke; 2020 Jan; 51(1):209-215. PubMed ID: 31662118
[TBL] [Abstract][Full Text] [Related]
7. Elevations in Tissue Fluid-Attenuated Inversion Recovery Signal Are Related to Good Functional Outcome after Thrombolytic Treatment.
Tanriverdi Z; Gocmen R; Oguz KK; Topcuoglu MA; Arsava EM
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):480-3. PubMed ID: 26652209
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-Weighted Imaging-Fluid-Attenuated Inversion Recovery Mismatch Is Associated with 90-Day Functional Outcomes in Patients Undergoing Mechanical Thrombectomy.
Sakakibara F; Yoshimura S; Numa S; Uchida K; Kinjo N; Morimoto T
Cerebrovasc Dis; 2020; 49(3):292-300. PubMed ID: 32544919
[TBL] [Abstract][Full Text] [Related]
9. Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database.
Nagel S; Wang X; Carcel C; Robinson T; Lindley RI; Chalmers J; Anderson CS;
Stroke; 2018 Jun; 49(6):1407-1411. PubMed ID: 29777016
[TBL] [Abstract][Full Text] [Related]
10. Fluid-attenuated inversion recovery images and stroke outcome after thrombolysis.
Ebinger M; Kufner A; Galinovic I; Brunecker P; Malzahn U; Nolte CH; Endres M; Fiebach JB
Stroke; 2012 Feb; 43(2):539-42. PubMed ID: 22033987
[TBL] [Abstract][Full Text] [Related]
11. Thrombolysis outcomes according to arterial characteristics of acute ischemic stroke by alteplase dose and blood pressure target.
Zhou Z; Xia C; Mair G; Delcourt C; Yoshimura S; Liu X; Chen Z; Malavera A; Carcel C; Chen X; Wang X; Al-Shahi Salman R; Robinson TG; Lindley RI; Chalmers J; Wardlaw JM; Parsons MW; Demchuk AM; Anderson CS
Int J Stroke; 2022 Jun; 17(5):566-575. PubMed ID: 34096413
[TBL] [Abstract][Full Text] [Related]
12. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
[TBL] [Abstract][Full Text] [Related]
13. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.
Koga M; Yamamoto H; Inoue M; Asakura K; Aoki J; Hamasaki T; Kanzawa T; Kondo R; Ohtaki M; Itabashi R; Kamiyama K; Iwama T; Nakase T; Yakushiji Y; Igarashi S; Nagakane Y; Takizawa S; Okada Y; Doijiri R; Tsujino A; Ito Y; Ohnishi H; Inoue T; Takagi Y; Hasegawa Y; Shiokawa Y; Sakai N; Osaki M; Uesaka Y; Yoshimura S; Urabe T; Ueda T; Ihara M; Kitazono T; Sasaki M; Oita A; Yoshimura S; Fukuda-Doi M; Miwa K; Kimura K; Minematsu K; Toyoda K;
Stroke; 2020 May; 51(5):1530-1538. PubMed ID: 32248771
[TBL] [Abstract][Full Text] [Related]
14. Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.
Aoki J; Sakamoto Y; Kimura K
J Neuroimaging; 2016 Jul; 26(4):414-9. PubMed ID: 27388586
[TBL] [Abstract][Full Text] [Related]
15. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996
[TBL] [Abstract][Full Text] [Related]
16. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.
Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS;
Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251
[TBL] [Abstract][Full Text] [Related]
17. Different Mismatch Concepts for Magnetic Resonance Imaging-Guided Thrombolysis in Unknown Onset Stroke.
Scheldeman L; Wouters A; Boutitie F; Dupont P; Christensen S; Cheng B; Ebinger M; Endres M; Fiebach JB; Gerloff C; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Thijs V; Thomalla G; Lemmens R;
Ann Neurol; 2020 Jun; 87(6):931-938. PubMed ID: 32227638
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.
Chen G; Wang X; Robinson TG; Pikkemaat M; Lindley RI; Zhou S; Ping L; Liu W; Liu L; Chalmers J; Anderson CS;
J Neurol Sci; 2018 Apr; 387():1-5. PubMed ID: 29571842
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of unknown symptom onset stroke patients with and without diffusion-weighted imaging and fluid-attenuated inversion recovery mismatch.
Thomalla G; Boutitie F; Fiebach JB; Simonsen CZ; Pedraza S; Lemmens R; Nighoghossian N; Roy P; Muir KW; Ebinger M; Ford I; Cheng B; Galinovic I; Cho TH; Puig J; Thijs V; Endres M; Fiehler J; Gerloff C
Int J Stroke; 2018 Jan; 13(1):66-73. PubMed ID: 28425349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
